Global GAAPP-Community
In 2009, a group of local and national asthma and allergy patient groups gathered in Buenos Aires, Argentina to establish GAAPP as a network linking organizations with a common interest: the support for and improvement of the quality of life of people around the globe who have allergies, airways or atopic diseases. Since we have grown into a vibrant worldwide organization with more than 55 constituent members from every continent sharing information and best practices, concerns and hopes.
While GAAPP is a patient-focused organization, we also work in concert with healthcare professionals, researchers and scientists, industry and governments to further the aspirations of people with allergies, airways and atopic diseases. Our mission is to help patients and their families through their journey with asthma, allergies and atopic diseases
Join our Activities
Videos
Webinar Library
Publications
Blog
Eosinophil-Driven Diseases – new content on GAAPP website
Type 2 Inflammatory Diseases Eosinophil-Driven Diseases (EDDs) are Type 2 [...]
Allergy and COVID-19 vaccination – important patient information
Dear patients, We would like to provide you with some [...]
Asthma drug to treat COVID-19?
Cortisone Spray containing Budesonide According to a study from Oxford [...]
“Long COVID”
Long-term consequences of COVID-19 After more than a year of [...]
COVID-19 Vaccines
Available vaccines against COVID-19 Infection. Vaccines are the most effective [...]
EU Approval: FIRST treatment for Peanut Allergy
In January 2021 the European Commission approved first treatment for [...]
English
Afrikaans
Amharic
Arabic
Bosnian
Chinese (Simplified)
Czech
Dutch
Finnish
French
German
Greek
Hindi
Italian
Japanese
Norwegian
Polish
Portuguese
Russian
Serbian
Slovenian
Spanish
Swahili
Swedish
Turkish
Vietnamese
Xhosa
Zulu